Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Drug DEXMEDITOMEDINE: On arrival in the ECT room, all patients will have standard monitoring like pulse oximetry
(SpO2), electrocardiography (ECG) and non- invasive blood pressure (NI
Sponsors
Pt B D Sharma post graduate institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: belonging to American Society of Anaesthesiologists (ASA) physical status of I-II, who are diagnosed with mood disorder and undergoing modified ECT
Exclusion criteria
Exclusion criteria: Following patients will be excluded from study 1)Refusal to consent by relatives 2) History of underlying renal, hepatic, cardiac and pulmonary diseases 3)History of head trauma 4) Patients who do not have seizures after receiving m – ECT.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1) Motor seizure duration (in seconds) 2) Time to spontaneous breathing (in seconds) 3) Responding time to verbal commands (in minutes)Timepoint: 1)SBP,SBP,MAP,HR,RPP at 1 min, 3 min,5 min,10 min and 20 min. 2)Motor seizure duration 3) Emergence agitation score at 30min | — |
Primary
| Measure | Time frame |
|---|---|
| Effect on hemodynamic responses and post ictal agitationTimepoint: 15 min before ECT and upto 20 min after ECT | — |
Countries
India
Contacts
Public ContactDr Kumili Raj Bhagavan
Pt B D Sharma post graduate institute of medical sciences
Outcome results
None listed